563: Real-life initiation of elexacaftor/ivacaftor/tezacaftor in cystic fibrosis patients with severe lung disease
2021 ◽
Vol 20
◽
pp. S265-S266
R. Kos
◽
A. Neerincx
◽
P. Brinkman
◽
R. Lub
◽
S. Vonk
◽
...
2017 ◽
Vol 16
(3)
◽
pp. 388-391
◽
Dominique Hubert
◽
Raphaël Chiron
◽
Boubou Camara
◽
Dominique Grenet
◽
Anne Prévotat
◽
...
James Chmiel
◽
Danielle Goetz
O. Fanthorpe
◽
S. Caskey
◽
D.G. Downey
2013 ◽
Vol 12
(5)
◽
pp. 530-531
◽
Hari M. Polenakovik
◽
Bradley Sanville
L. Everitt
◽
G. Connett
◽
A. Dewar
◽
W. Verling
G. Spoletini
◽
N. Shaw
◽
C. Etherington
◽
I. Clifton
◽
P. Whitaker
◽
...
2015 ◽
Vol 50
(11)
◽
pp. 1082-1089
◽
Alex Gileles-Hillel
◽
David Shoseyov
◽
Itzhack Polacheck
◽
Maya Korem
◽
Eitan Kerem
◽
...
Koliarne Tong
◽
Douglas Dorahy
◽
Megan France
◽
Lucy Burr
◽
Hugh Greville
◽
...
2002 ◽
Vol 19
(3)
◽
pp. 504-510
◽
D.R. Dancey
◽
E.D. Tullis
◽
R. Heslegrave
◽
K. Thornley
◽
P.J. Hanly
2006 ◽
Vol 41
(3)
◽
pp. 234-241
◽
Bareket Falk
◽
Asaph Nini
◽
Levana Zigel
◽
Yaacov Yahav
◽
Micha Aviram
◽
...